Trials suggest that abatacept may delay rheumatoid arthritis in carefully selected high-risk patients, but permanent prevention remains unproven.

The association remains significant after accounting for estradiol, progesterone, and vasomotor symptoms, though the findings are not yet clinically applicable.

Mood changes, anxiety, and brain fog are more common complaints than itching or wheezing, and experts caution that the survey cannot establish cause and effect.

Many patients never connect diabetes with changes in sexual health, leaving clinicians to recognize concerns that may otherwise go unspoken during routine care.

An international panel calls for managing traumatic brain and spinal cord injuries as lifelong conditions, not one-time events.

Patients with bloodstream infections who have immunosuppression show distinct pathogen profiles and face higher short-term death rates than those who are immunocompetent.

Primary care clinicians can help improve survival and quality of life in patients with cirrhosis through many simple preventive measures, according to a new clinical guideline from the American ...

This digest highlights FDA actions in October related to therapeutics and devices for neurologic illness. For information on approvals in other specialties during 2026, see our FDA Drug Approvals page ...

Patients with head and neck cancer who attended a survivorship clinic before completing RT were more likely to complete treatment on schedule and had better 3-year DFS than those who did not attend.